Tenet Healthcare Corporation $THC Shares Acquired by WINTON GROUP Ltd

WINTON GROUP Ltd increased its stake in Tenet Healthcare Corporation (NYSE:THC) by 129.4% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,900 shares of the company’s stock after buying an additional 2,200 shares during the period. WINTON GROUP Ltd’s holdings in Tenet Healthcare were worth $730,000 at the end of the most recent reporting period.

Several other hedge funds also recently added to or reduced their stakes in THC. California State Teachers Retirement System increased its position in shares of Tenet Healthcare by 18,362.2% in the 2nd quarter. California State Teachers Retirement System now owns 18,885,726 shares of the company’s stock worth $3,533,142,000 after purchasing an additional 18,783,432 shares during the last quarter. Boston Partners lifted its position in shares of Tenet Healthcare by 15.7% during the fourth quarter. Boston Partners now owns 3,642,136 shares of the company’s stock worth $723,804,000 after purchasing an additional 494,581 shares during the last quarter. Norges Bank acquired a new position in Tenet Healthcare in the fourth quarter worth about $248,494,000. Manning & Napier Advisors LLC bought a new stake in Tenet Healthcare in the second quarter valued at about $168,761,000. Finally, Allianz Asset Management GmbH raised its stake in Tenet Healthcare by 78.1% during the fourth quarter. Allianz Asset Management GmbH now owns 868,134 shares of the company’s stock valued at $172,516,000 after buying an additional 380,632 shares in the last quarter. 95.44% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

THC has been the subject of a number of research analyst reports. Weiss Ratings upgraded Tenet Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a report on Thursday, August 20th. Robert W. Baird raised their price objective on Tenet Healthcare from $210.00 to $280.00 and gave the stock a “neutral” rating in a research note on Tuesday, July 28th. Truist Financial boosted their target price on shares of Tenet Healthcare from $270.00 to $290.00 and gave the company a “buy” rating in a research note on Tuesday, July 28th. Cantor Fitzgerald restated an “overweight” rating on shares of Tenet Healthcare in a research report on Monday, July 27th. Finally, Morgan Stanley lifted their price target on shares of Tenet Healthcare from $254.00 to $274.00 and gave the company an “overweight” rating in a report on Monday, July 27th. One investment analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Buy” and an average target price of $275.53.

Tenet Healthcare Price Performance

Shares of THC opened at $264.85 on Tuesday. Tenet Healthcare Corporation has a 12 month low of $157.58 and a 12 month high of $283.05. The company has a debt-to-equity ratio of 2.00, a current ratio of 1.41 and a quick ratio of 1.35. The stock has a fifty day moving average price of $246.18 and a 200 day moving average price of $212.44. The company has a market cap of $21.33 billion, a P/E ratio of 10.21, a PEG ratio of 1.01 and a beta of 1.23.

Tenet Healthcare (NYSE:THC) last posted its earnings results on Thursday, July 23rd. The company reported $6.12 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.26 by $1.86. The company had revenue of $6.04 billion for the quarter, compared to analysts’ expectations of $5.43 billion. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%.The firm’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same period last year, the business posted $4.02 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. On average, research analysts forecast that Tenet Healthcare Corporation will post 21.04 earnings per share for the current year.

Insider Activity

In other Tenet Healthcare news, Director Richard Mark sold 10,000 shares of the company’s stock in a transaction dated Thursday, September 10th. The shares were sold at an average price of $263.42, for a total value of $2,634,200.00. Following the completion of the transaction, the director owned 25,121 shares in the company, valued at approximately $6,617,373.82. This represents a 28.47% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Tammy Romo sold 4,922 shares of Tenet Healthcare stock in a transaction that occurred on Thursday, August 6th. The shares were sold at an average price of $264.15, for a total value of $1,300,146.30. Following the sale, the director directly owned 30,784 shares in the company, valued at approximately $8,131,593.60. This trade represents a 13.78% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 119,189 shares of company stock worth $31,898,309 over the last three months. Insiders own 0.97% of the company’s stock.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified healthcare services company that owns and operates acute care hospitals and other healthcare facilities in the United States. Its hospitals provide services including emergency care, surgery, cardiovascular care, orthopedics, oncology, women’s health and other inpatient and outpatient treatments.

Through its ambulatory business, United Surgical Partners International, Tenet operates and manages ambulatory surgery centers and other outpatient facilities.